NASDAQ: CRSP
Crispr Therapeutics Ag Stock Ownership - Who owns Crispr Therapeutics Ag?

Insider buying vs selling

Have Crispr Therapeutics Ag insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Simeon GeorgeDirector2025-07-166,510$52.03
$338.72kBuy
Simeon GeorgeDirector2025-07-1622,319$52.03
$1.16MBuy
Simeon GeorgeDirector2025-07-16960,983$52.03
$50.00MBuy
Naimish PatelChief Medical Officer2025-05-293,932$35.94
$141.32kSell
Samarth KulkarniChief Executive Officer2025-03-2110,031$41.23
$413.58kSell
Julianne BrunoChief Operating Officer2025-03-211,714$41.23
$70.67kSell
Raju PrasadChief Financial Officer2025-03-212,197$41.23
$90.58kSell
James R. KasingerGeneral Counsel and Secretary2025-03-213,185$41.23
$131.32kSell
Raju PrasadChief Financial Officer2025-03-173,762$41.80
$157.25kSell
James R. KasingerGeneral Counsel and Secretary2025-03-121,116$43.32
$48.35kSell

1 of 3

CRSP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CRSP insiders and whales buy or sell their stock.

CRSP Shareholders

What type of owners hold Crispr Therapeutics Ag stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Ark Investment Management LLC11.77%10,165,400$648.04MInstitution
Celgene Corp9.91%8,557,514$545.54MInsider
Capital International Investors7.03%6,073,118$387.16MInstitution
Vertex Pharmaceuticals Europe Ltd6.23%5,380,940$343.03MInsider
Simeon George6.09%5,259,390$335.29MInsider
Bayer Global Investments Bv5.91%5,105,330$325.46MInsider
T Rowe Price Investment Management Inc4.40%3,798,103$242.13MInstitution
Glaxosmithkline PLC3.73%3,220,627$205.31MInsider
Blackrock Inc3.03%2,613,539$166.61MInstitution
Sumitomo Mitsui Trust Group Inc2.94%2,539,889$161.92MInstitution

1 of 3

CRSP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CRSP65.13%34.87%Net BuyingNet Buying
AXSM70.09%29.91%Net BuyingNet Selling
RYTM87.51%12.49%Net SellingNet Buying
TGTX55.59%44.41%Net SellingNet Selling
MRUS90.21%9.79%Net BuyingNet Buying

Crispr Therapeutics Ag Stock Ownership FAQ

Who owns Crispr Therapeutics Ag?

Crispr Therapeutics Ag (NASDAQ: CRSP) is owned by 74.27% institutional shareholders, 39.76% Crispr Therapeutics Ag insiders, and 0.00% retail investors. Celgene Corp is the largest individual Crispr Therapeutics Ag shareholder, owning 8.56M shares representing 9.91% of the company. Celgene Corp's Crispr Therapeutics Ag shares are currently valued at $505.06M.

If you're new to stock investing, here's how to buy Crispr Therapeutics Ag stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.